Bow Street’s Tandem Diabetes Care TNDM Stock Holding History

Bow Street’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-5,625	Closed	-$1.45M	–	35
2013 Q4	$1.45M	Buy	+5,625	New	+$1.29M	0.67%	28

Other funds holding TNDM

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TCP

TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MACM

March Altus Capital Management Greenwich, Connecticut $16M AUM 18.92% 1-Year Est. Return

Bow Street's TNDM Position: Q1 2014 in Review

Bow Street sold out of Tandem Diabetes Care (TNDM) in Q1 2014, closing a stake of 5,625 shares — an estimated $1.45M sold.

Bow Street first reported a position in TNDM in Q4 2013 and held it in 1 quarter. The position peaked at $1.45M in Q4 2013. 65 funds tracked by Wall St. Rank hold TNDM as of Q1 2014.

Bow Street reported no remaining Tandem Diabetes Care position as of Q1 2014 after selling out during the quarter.
Bow Street sold 5,625 Tandem Diabetes Care shares in Q1 2014, an estimated $1.45M.
Bow Street first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 1 quarter.
Bow Street's Tandem Diabetes Care position peaked at $1.45M in Q4 2013.
65 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2014.

Based on Bow Street's 13F filing for Q1 2014, filed 14 May 2014.